2.Materials and Methods
In this experimental study, all chemicals were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA) (exceptions included).2.1.Preparation of alcoholic NS extraction
The seeds of NS were purchased from a local herb market and the taxonomic identification of the seeds was confirmed by a senior plant taxonomist while giving the herbarium number of PMP-1735. The extract was prepared according to the Word Health Organization (WHO) protocol CG-04 (16). The dried seeds (100 gr) were powdered and then applied to Soxhlet for the extraction with 50% ethanol. The resultant alcoholic extract was filtered using a filter paper (Whatman No. 3) and then evaporated at 40ºC to dry in vacuum. The extract was stored at -20ºC until use (yield 12%). A stock solution of NSE was prepared in dimethyl sulfoxide (DMSO), and suitable working concentrations were prepared from the stock using a complete medium. The stock solution of NS was prepared as 100 mg/ml in DMSO, and was diluted in IVM medium to reach the final concentrations of 0, 1, 50, and 100 µg/ml. In the control group, oocytes were only cultured in IVM medium containing 0.1% (v/v) of DMSO (final concentration of DMSO ≤ 0.1%). No difference was observed between the presence or absence of DMSO, indicating that the DMSO at the tested concentrations did not influence the results.2.2.Induction and validation of PCOS mice model
In this experimental study, 80 prepubertal 21-day old female B6D2F1 (18-22 g body weight) mice were randomly divided into two groups, treatment and control (n = 40/ each). They were housed in an animal room with an ambient temperature of 20-24°C and a 12 hr light/dark cycle. All mice had free access to food and water. They received a daily subcutaneous shot of either a mixture of 100 µl solution of dehydroepiandrosterone (DHEA) 60 mg/kg body weight dissolved in a 9/1 mixture of sesame oil/95% ethanol (treatment) or 100 µl sesame oil/95% ethanol (control) for 20 consecutive days. Model validity was described and confirmed by acyclicity, ovarian histopathology and hormonal abnormality in our recent study (15, 17). During oocyte quality assessment, 2 to 3 mice per group were used in each experiment except for 3 or 5 per group used in IVM and IVF.2.3.Collection of mice oocytes
After PCOS confirmation, the mice in both groups, 6-8 wks of age, were superovulated with intraperitoneal injection of 10 IU pregnant mare’s serum gonadotropin and sacrificed 46-48 hr later. Both the ovaries were excised and washed twice in 37ºC sterile physiological saline (containing 100 IU/L penicillin and 50 mg/L streptomycin). Cumulus oocyte complexes (COCs) were physically retrieved fromantral follicles (2-8 mm in diameter) in HEPES-buffered tissue culture medium using a pair of 27-G needles under a stereomicroscope (Nikon, SMZ645, Tokyo, Japan). The buffer was improved with 5% (v/v) heat-inactivated fetal bovine serum (FBS; GIBCO BRL Invitrogen, USA). After washing 3-times with tissue culture medium (TCM-199), only the COCs with at least three layers of compact cumulus cells and uniform ooplasm were taken as normal for use in all experiments. Approximately 20-30 COCs per animal were isolated from the mice (17).2.4.In vitro maturation
Maturation medium contained of TCM-199, supplemented with 10 μg/mL follicle-stimulating hormone (FSH), 10 μg/mL luteinizing hormone (LH), 10% (v/v) fetal bovine serum (FBS, 24.2 mg/l sodium pyruvate, and 1 μg/ml 17-β estradiol at 37ºC and 5% CO2. Then, immediately, NSE from prepared stock was added to the maturation medium for preparation of different IVM groups (0, 1, 50, and 100 µg/ml). After that, a total number of 10-15 normal COCs were cultured in 50 µL microdrop of 4 mentioned concentrations. The oocytes were then separated from cumulus cells by mechanical pipetting after 22-24 hrs. The first polar body extrusion was considered as the criteria for the metaphase II (MII)-stage oocyte rate. Moreover, oocytes were selected according to normal morphological criteria with a round, clear zona pellucida, a small perivitelline space, and a pale moderately granular cytoplasm that did not contain inclusions (18). Only normal oocytes were used in following tests.2.5.In vitro fertilization and embryo culture
After oocyte maturation, IVF was performed with normal spermatozoa retrieved from the cauda-epididymis and vas deferens of 10-12-wk-old B6D2F1 male mice in different IVM groups. The washed sperm were capacitated in enhanced ham’s-F10 with 5 mg/ml BSA. Then, Groups of 20 MII oocytes were placed to 120 μl fertilization droplets (potassium simplex optimized medium, KSOM, with 15 mg/ml BSA) with capacitated spermatozoa at the concentration of about 3 × 106/ml. Then, dishes were incubated for 6 hrs. at 37ºC in a humidified 5% CO2 atmosphere. Fertilization was evaluated by the observation of two pronuclei (2PN). Finally, the culture was done in 30 μl of culture droplets (KSOM supplemented with 4 mg/ml BSA) (one embryo per 2 µl) under mineral oil. The day of insemination was taken as day 0, and the cleavage rate was evaluated 24 hrs. later. The blastocyst rate was documented at the end of day 5 (17).2.6.Measurement of intracellular ROS and GSH levels
In order to detection of intracellular ROS and GSH levels, the 2¢,7¢-dichlorodihydrofluorescein diacetate (H2DCFDA; Cell Tracker Green; Molecular Probes, Invitrogen, USA) and 4-chloromethyl-6, 8-difluoro-7-hydroxycoumarin (CMF2HC; Cell Tracker Blue; Molecular Probes, Invitrogen, USA) were used. For this, the oocytes were incubated for 30 mins. At 37ºC in 10 µM droplet of each marker as described previously (19). The incubated oocytes were analyzed for florescence intensity using fluorescence microscope (Labomed Lx 400; Labo America) with ultraviolet filters (460 nm for intracytoplasmic ROS, 370 nm for GSH). The details were described in our recent study (17).2.7.RNA isolation and quantitative real-time polymerase chain reaction
After denuding and washing of mature oocytes, 10-15 oocytes were accumulated four times, and total RNA was isolated from these accumulations. The RNeasy Micro kits (Qiagen Inc., Valencia, CA, USA) and transcript nova kit (Qiagen Inc., Valencia, CA, USA) were used for RNA isolation and reverse-transcription into cDNA as a described previously (20). The reverse-transcribed yields of two subunits of maturation-promoting factor (MPF: Cdk1, cyclin B), mitogen-activated protein kinase (Mapk), Cyclooxygenase (Cox2), Glutathione peroxidase (Gpx1), DNA methyltransferase-1 (Dnmt1) and histone deacethylase-1 (Hdac1) were amplified by real-time polymerase chain reaction (PCR) with SYBR Green (Takara, Japan) on an ABI real-time PCR system (Applied Biosystems, ABI, Foster City, CA, USA), according to the manufacturer’s instructions. Finally, all data were analyzed by the standard formula, while glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as an internal reference gene. The details of real-time PCR reaction was described in our previous article (17). Table I lists the primer sequences.3.Results
3.1.Effect of NSE on oocyte maturation
Table II and III summarizes the results of oocyte maturation and abnormal morphologh in both control and PCOS groups with different concentrations of NSE during IVM. They show that MII rate was significantly higherand the abnormality rate was lower in the control group than in the PCOS model with 0 and 1 µg/ml NSE concentrations respectively (Table II). The percentage of MII oocytes in the PCOS oocytes was significantly higher in 1, 50, and 100 µg/ml of NSE than the control. However, only supplementation with 50 µg/ml NSE had a strong effect on the reduction of abnormality rate in PCOS-treated oocytes as compared to the control. In the control group, the MII rate was significantly higher in 1 and 50 µg/ml of NSE concentrations when compared to the control. Besides, the reduction of abnormality was significantly lower in 1 and 50 µg/ml NSE-treated oocytes as compared to the control. Finally, a comparison of abnormality rate for different concentrations of NSE showed that lower and higher-value concentrations cannot reduce the abnormality rate (Table III).3.2.Effect of NSE on embryonic development
Table IV and V summarizes the results of embryonic development following the maturation of oocytes, via IVM. Fertilization, 2-cell, 8-cell, and blastocyst rates were significantly higher in the control than in the PCOS group of untreated oocytes. In 1 µg/ml NSE group only fertilization rate was higher in the control than in the PCOS group (Table IV). In the control mice, the fertilization rate was not different across different concenterations of NSE; however, the 2-cell, 8-cell, and blastulation rates were significantly higher in 50 µg/ml NSE-treated oocytes in comparison with the untreated. Moreover, fertilization, 2-cell, 8-cell, and blastulation rates were significantly higher in the 50 µg/ml NSE-treated PCOS mice oocytes than the untreated (Table V).3.3.Antioxidant effect of NSE on ooplasmic GSH and ROS levels and Gpx1 gene expression
The CellTracker™ Blue and Green dyes were used to detect intracytoplasmic GSH (Figure 1) as blue fluorescence and ROS (Figure 2) as green fluorescence, respectively. In these two figures, the enhanced fluorescent intensity of the oocytes is representative of more GSH and ROS levels. In this regard, our results showed that the GSH and Gpx1 mRNA expression levels were significantly higher in the control than the PCOS. The details are shown in Figure 1. Moreover, both the control and PCOS oocytes showed an increase in intracellular GSH level in the 1 (227.9 ± 12.64 vs 191.3 ± 8.38, p= 0.017 and 158 ± 6.32 vs 102.83 ± 3.14, p = 0.0083) and 50 (236.9 ± 12.64 vs 191.3 ± 8.38, p = 0.0057 and 164.67 ± 15.8 vs 102.83 ± 3.14, p = 0.0023) µg/ml NSE-treated oocytes as compared to the untreated oocytes, respectively (Figure 1). However, the intracellular ROS level was significantly lower in the control group than the PCOS. Furthermore, the intracellular ROS levels were significantly lower in the control and PCOS oocytes treated with 1 (103.9 ± 11.46 vs 165.4 ± 12.86, p = 0.023 and 141 ± 13.85 vs 220.21 ± 6.97, p = 0.0067) and 50 (94.7 ± 17.0 vs 165.4 ± 12.86, p = 0.0081; 131 ± 12.19 vs 220.21 ± 6.97, p = 0.0035) µg/ml NSE as compared to untreated oocytes, respectively (Figure 2). In addition, the Gpx1 expression was significantly higher in 50 µg/ml NSE-treated group versus untreated oocytes in both control (1.8 ± 0.06 vs 1.33 ± 0.06, p = 0.043) and PCOS (1.47 ± 0.08 vs 1.03 ± 0.03, p = 0.015) groups (Figure 1).3.4.Effect of NSE on MPF (Cdk1 & Cyclin B) and MAPK genes expression
As an assessment of oocyte nuclear maturation, three nuclear maturation-related genes were evaluated in real-time PCR. In the control group, Cyclin B (0.96 ± 0.09 vs 0.56 ± 0.06, p = 0.022), Cdk1 (1.03 ± 0.12 vs 0.56 ± 0.09, p = 0.035), and Mapk (0.96 ± 0.18 vs 0.47 ± 0.13, p = 0.041) mRNA levels were significantly higher than PCOS. The details are shown in Figure 3. However, the Cdk1 mRNA expression was significantly higher in the 50 µg/ml NSE-treated oocytes than that the untreated in both control (1.47 ± 0.11 vs 1.03 ± 0.05, p = 0.037) and PCOS (1.17 ± 0.23 vs 0.56 ± 0.09, p = 0.012). Although, treatment with NSE had no effect on the gene expression of Cyclin B., the Mapk mRNA expression in both control (1.85 ± 0.06 vs 0.96 ± 0.18, p = 0.025) and PCOS (1.2 ± 0.09 vs 0.47 ± 0.13, p = 0.0067) mice oocytes was significantly higher in 50 µg/ml NSE-treated oocytes than in the untreated (Figure 3).3.5.Effect of NSE on Cox2 genes expression
In order to assess the inhibitory effect of NSE on the apoptotic pathway, the Cox2 gene expression was evaluated in mature oocytes. Cox2 mRNA expression was significantly decreased in the 50 µg/ml NSE-treated oocytes as compared to the untreated in both control (0.82 ± 0.08 vs 1.33 ± 0.08, p = 0.047) and PCOS (1.09 ± 0.06 vs 1.63 ± 0.08, p = 0.035) groups. Moreover, the results showed that there was no significant difference in Cox2 expression between the PCOS and control mice in all groups of NSE concentrations (Figure 4).3.6.Effect of NSE on the expression of epigenetic-related gene (Hdac1 and Dntm1)
Epigenetic defects particularly reduce DNA methylation and interfere with the transcription of certain enzymes in oocytes. The expression of enzymes may also be affected by ROS production. Therefore, our results showed that the Dnmt1 and Hdac1 mRNA levels were significantly higher in the control than the PCOS group. The details are shown in Figure 5. Moreover, during IVM, treatment with 50 µg/ml NSE resulted in higher gene expression of Dnmt1 (1.4 ± 0.17 vs 0.56 ± 0.09, p = 0.0071), (1.24 ± 0.03 vs 0.54 ±0.03, p = 0.014) and Hdac1 (1.1 ± 0.12 vs 0.52 ±0.09, p = 0.0097), (1.06 ± 0.12 vs 0.52 ±0.04, p = 0.0065) levels in comparison to untreated oocytes in both control and PCOS mice, respectively (Figure 5).4.Discussion
The present research showed that maturation, developmental competency, epigenetic alteration, and oxidative statues were significantly different between the control and PCOS mice oocytes. Moreover, these results showed that 50 µg/ml NS NSE in culture medium was associated with a significant increase in Dnmt1, Hdac1, Cdk1, Mapk, and Gpx1 genes and a significant decrease of Cox2 gene expression of mature oocytes. Moreover, we found that both 1 and 50 µg/ml NSE in the PCOS and control mice had lower levels of ROS and higher levels of GSH than those in other groups during oocyte maturation. Since cdk1 and Mapk are two key genes in oocyte maturation (22), in addition to the fact that Dnmt1 and Hdac1 are two essential genes for normal epigenetic modification and development (11), the difference in the maturation fertilization and embryonic development outcome may be partly induced by the expression alterations of genes in the oocytes of the PCOS and control groups.Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |